(19)
(11) EP 1 433 792 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION

(48) Corrigendum issued on:
06.10.2004 Bulletin 2004/41

(43) Date of publication:
30.06.2004 Bulletin 2004/27

(21) Application number: 04005422.3

(22) Date of filing: 23.05.2001
(51) International Patent Classification (IPC)7: C07K 14/705, C07K 16/28, C12N 15/12, C12N 15/62, C12N 5/10, C12N 1/21, A61K 38/17, A61K 39/395
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
RO SI

(30) Priority: 25.05.2000 US 207558 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
01939361.0 / 1283849

(71) Applicant: SCHERING CORPORATION
Kenilworth, New Jersey 07033-0530 (US)

(72) Inventors:
  • Hardiman, Gerard T.
    San Diego, CA 92128 (US)
  • Rock, Fernando L.
    La Honda, CA 94020 (US)
  • Bazan, J. Fernando
    Palo Alto, CA 94301 (US)
  • Kastelein, Robert A.
    Redwood City, CA 94062 (US)
  • Ho, Stephen W.K.
    Sunnywale, CA 94087 (US)
  • Liu, Yong-Jun
    Palo Alto, CA 94306 (US)

(74) Representative: Taylor, Kathryn May et al
Mathys & Squire, 100 Gray's Inn Road
London WC1X 8AL
London WC1X 8AL (GB)

 
Remarks:
This application was filed on 08 - 03 - 2004 as a divisional application to the application mentioned under INID code 62.
 


(54) Human receptor proteins, related reagents and methods


(57) Nucleic acids encoding mammalian, e.g., human receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.